Ralph E Robinson

US Patent:

7368573, May 6, 2008

Filed:

Jun 15, 2006

Appl. No.:

11/424488

Inventors:

Peter Bertinato - Old Lyme CT, US
Michel A. Couturier - Pawcatuck CT, US
Ernest S. Hamanaka - Gales Ferry CT, US
Marcus D. Ewing - Colchester CT, US
Ralph P. Robinson - Gales Ferry CT, US
Derek L. Tickner - Waterford CT, US

Assignee:

Pfizer Inc. - New York NY

International Classification:

C07D 215/38
C07D 215/46
A61K 31/47

US Classification:

546162, 546163, 514313

Abstract:

This invention relates to MTP/Apo-B secretion inhibitors of Formula (I).

US Patent:

7393958, Jul 1, 2008

Filed:

Oct 30, 2006

Appl. No.:

11/554351

Inventors:

Peter Bertinato - Old Lyme CT, US
Michel A. Couturier - Pawcatuck CT, US
Ernest S. Hamanaka - Gales Ferry CT, US
Marcus D. Ewing - Colchester CT, US
Ralph P. Robinson - Gales Ferry CT, US
Derek L. Tickner - Waterford CT, US

Assignee:

Pfizer, Inc. - New York NY

International Classification:

C07D 215/38
A61K 31/47

US Classification:

546156, 514312

Abstract:

This invention relates to MTP/Apo-B secretion inhibitors of Formula (I).

US Patent:

7468378, Dec 23, 2008

Filed:

Feb 3, 2005

Appl. No.:

11/049852

Inventors:

Peter Bertinato - Old Lyme CT, US
Michel A. Couturier - Pawcatuck CT, US
Ernest S. Hamanaka - Gales Ferry CT, US
Marcus D. Ewing - Colchester CT, US
Ralph P. Robinson - Gales Ferry CT, US
Derek L. Tickner - Waterford CT, US

Assignee:

Pfizer Inc. - New York NY

International Classification:

A61K 31/44
C07D 275/04

US Classification:

514312, 546156

Abstract:

This invention relates to MTP/Apo-B secretion inhibitors of Formula (I).

US Patent:

20100285145, Nov 11, 2010

Filed:

May 6, 2010

Appl. No.:

12/774965

Inventors:

Etzer Darout - New Haven CT, US
Michael P. DeNinno - San Diego CA, US
Kentaro Futatsugi - Niantic CT, US
Cristiano Guimaraes - Clinton CT, US
Bruce A. Lefker - Gales Ferry CT, US
Vincent Mascitti - Groton CT, US
Kim F. McClure - Mystic CT, US
Michael J. Munchhof - Salem CT, US
Ralph P. Robinson - Gales Ferry CT, US

International Classification:

A61K 31/506
C07D 498/08
C07D 401/14
C07D 471/04
C07D 487/04
A61K 31/55
A61K 31/536
A61K 31/566
A61K 38/22
A61K 38/26
A61K 31/64
A61K 31/702
A61K 38/16
A61P 3/10
A61P 3/04
A61K 35/56
A61P 9/00
A61P 25/00
A61P 1/00

US Classification:

424520, 544328, 514269, 544236, 514248, 51421301, 5142305, 514171, 514 53, 514250, 51421711, 514 61, 514 69

Abstract:

Compounds of Formula (I) that modulate the activity of the G-protein-coupled receptor GPR119 and their uses in the treatment of diseases linked to the modulation of the G-protein-coupled receptor GPR119 in animals are described herein.

US Patent:

43084354, Dec 29, 1981

Filed:

May 31, 1979

Appl. No.:

6/044250

Inventors:

David Morrison - Atlanta GA
Ralph C. Robinson - Charlotte NC

Assignee:

General Time Corporation - Thomaston CT

International Classification:

H01H 300

US Classification:

200 17R

Abstract:

One or more switch apparatus for controlling a digital display of a changing function each include stationary and movable contacts and an actuator having a rest position and movable longitudinally in opposite directions to second and third positions. Cam structure is supported on each actuator to interact with a follower carried by each movable contact whereby different conditions of switch operation may be indicated by the position of the actuator relative to the movable contact. Biasing structure intercooperates between each actuator and a support for biasing the actuator toward the rest position from at least one of the second and third positions. A latch, also, intercooperates with each actuator to latch the actuator in one of the last-mentioned positions.